Category: Resources

The Positive Living Society of British Columbia has just published a resource aimed at helping PLHIV talk with others about their HIV status, and reducing HIV stigma. It is entitled “Disclosure: Telling Someone You Are Living with HIV.” This new resource is based on the lived experience of PLHIV and includes helpful information on planning… Read more »

The number of BC PharmaCare covered hep C treatments has been increasing and so has the information gathered by the Hepatitis C Treatment Information Project. The Hep C TIP now has new pages dedicated to BC’s PharmaCare and the treatments that are covered by it. These pages are: Treatments Targeted Genotype Ribavirin with Pegylated Interferon… Read more »

CATIE HepCinfo Update 6.6

New warning issued for serious heart problems when Harvoni or sofosbuvir is taken with amiodarone The U.S. Food and Drug Administration (FDA) is warning that serious slowing of the heart rate (symptomatic bradycardia) can occur when the drug amiodarone, which is used to treat an irregular heartbeat, is taken together either with Harvoni or with… Read more »

Background Case reports are the basis of most sexually-transmitted infection (STI) reporting systems, but reliance on case data alone is limited by an inability to describe trends among key populations, such as gay, bisexual and other men who have sex with men (MSM). Sentinel surveillance, in which disease monitoring is done at select sites when… Read more »

GetCheckedOnline Internet-Based Testing Program

From BCCDC: Internet-based service makes it easier to test for STIs, HIV and Hep C The BC Centre for Disease Control (BCCDC) has gone live with GetCheckedOnline, the first online service in Canada offering easy, convenient testing for sexually transmitted infections (STIs) including HIV, and Hepatitis C. The new service, which is starting as a… Read more »

CATIE Treatment Update 208

In this issue: HEPATITIS C VIRUS Grazoprevir + elbasvir and other emerging drugs Enter ledipasvir Sirius—ledipasvir + sofosbuvir in cases of severe liver injury Using ledipasvir + sofosbuvir when prior treatment with sofosbuvir failed Grading severe liver disease and predicting survival Ledipasvir + sofosbuvir with or without ribavirin in people with liver transplants Solar-1—ledipasvir +… Read more »

by Shazia Masud, PGY-3 Medical Microbiology, UBC Purpose of the study Lymphogranuloma venereum (LGV) is a sexually transmitted infection (STI) caused by Chlamydia trachomatis serovars L1, L2, and L3. Depending on the site of inoculation, LGV can manifest either as an inguinal syndrome with a unilateral painful inguinal lymphadenopathy (buboes) or as an anorectal syndrome… Read more »

CATIE’s HepC Info Update 6.5

New and Noteworthy Holkira Pak cures 94% of people co-infected with Hep C and HIV High cure rates for Harvoni in people co-infected with HIV and Hep C Hep C testing program in an emergency department finds undiagnosed older adults with Hep C

CATIE Treatment Update 207

  I HEPATITIS C VIRUS About some terms – SVR12 vs. SVR24 SVR linked to longer survival and other benefits Issues with emerging therapies for HCV Simeprevir + sofosbuvir – experience in the clinic Holkira Pak approved in Canada for genotype 1 Holkira Pak – results in genotype 1a without severe liver injury Holkira Pak… Read more »